Clinical Trials
All Clinical Trials - Page 31 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02944500Phase 4Active Not Recruiting
Saxenda: Underlying Mechanisms and Clinical Outcomes
Liraglutide
- NCT02910570Phase 4Completed
Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis
Liraglutide
- NCT02931383Phase 4Completed
Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
Liraglutide
- NCT02928679Phase 4Completed
Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
Liraglutide
- NCT02905864Phase 4Completed
Liraglutide 3 mg for Knee Osteoarthritis
Liraglutide
- NCT02848313Phase 1Completed
An Open-Label, Phase 1 Clinical Study to Evaluate the Safety and Tolerability of Subcutaneous Elamipretide in Subjects With Intermediate Age-Related Macular Degeneration
Elamipretide
- NCT03096847Phase 3Completed
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer
Ghrp-6
- NCT02914665Phase 2Completed
A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure
Elamipretide
- NCT02903368Phase 2Completed
Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy
Gonadorelin
- NCT03141632Phase 2Completed
Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake
Dulaglutide
- NCT02920385Phase 1Completed
A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Levothyroxine and the Influence of Co-administered Tablets on the Pharmacokinetics of Semaglutide Administered Orally in Healthy Subjects.
Semaglutide
- NCT03182231Phase 1/Phase 2Unknown
GLP1-imaging Before and After Bariatric Surgery
Exenatide
- NCT02931474Phase 2Withdrawn
Impact of GHRH on Sleep Promotion and Endocrine Regulation in Service Members Who Sustained a Traumatic Brain Injury and Have Current Insomnia
Tesamorelin
- NCT02889510Phase 3Completed
Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
Liraglutide
- NCT02906163Phase 1/Phase 2Unknown
First Line Bio-immunotherapy With Thymosin Alpha 1 in Patients With Sensitizing EGFR Mutation Positive Non Small Cell Lung Cancer Who Are Taking Standard of Care Therapy
Thymosin-Alpha-1
- NCT02901379Phase 3Completed
Effect of 80-mg Atorvastatin on Myocardial Edema
Follistatin
- NCT02918279Phase 3Completed
Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity
Liraglutide
- NCT02793154Phase 4Terminated
An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
Exenatide
- NCT02911948Phase 3Completed
A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
Liraglutide
- NCT02849080Phase 3Completed
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.
Semaglutide
- NCT02827708Phase 3Completed
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Semaglutide
- NCT02802514Phase 4Terminated
A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
Exenatide
- NCT02867267Phase 3Completed
The Efficacy and Safety of Ta1 for Sepsis
Thymosin-Alpha-1
- NCT02894398Phase 2Completed
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant
Gonadorelin
- NCT02814097Phase 2Completed
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
Elamipretide
- NCT04012632N/ACompleted
Kisspeptin/GPR54 Pathway and Early Puberty
Kisspeptin
- NCT02906150Phase 2Unknown
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type
Thymosin-Alpha-1
- NCT02935023Phase 2Unknown
Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer
Gonadorelin
- NCT02911818Phase 4Completed
Lifestyle Modification and Liraglutide
Liraglutide
- NCT04122716Phase 4Unknown
Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet
Liraglutide
- NCT02743598Phase 4Terminated
Liraglutide for HIV-associated Neurocognitive Disorder
Liraglutide
- NCT02930265N/AUnknown
Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy
Liraglutide
- NCT02877355Phase 1Completed
Investigation of the Effect of Upper Gastrointestinal Disease on the Pharmacokinetics of Oral Semaglutide in Subjects With Type 2 Diabetes.
Semaglutide
- NCT02805790Phase 2Completed
Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study
Elamipretide
- NCT02870231Phase 1Completed
Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity
Liraglutide
- NCT02843399N/ACompleted
Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy
Exenatide
- NCT02863328Phase 3Completed
Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
Semaglutide
- NCT02863419Phase 3Completed
Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus
Semaglutide
- NCT04325581Phase 3Completed
Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients
Liraglutide
- NCT02734641N/ACompleted
Does Increase in Appetite After Iron Treatment Induced by Ghrelin Hormone
Ghrp-6
- NCT02827656N/AUnknown
Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS
Gonadorelin
- NCT02895672N/ACompleted
GLP-1/Basal Insulin Combination Therapy
Liraglutide
- NCT02846233N/ACompleted
Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
Dulaglutide
- NCT02750410Phase 4Completed
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
Dulaglutide
- NCT02829502Phase 2Unknown
The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke
Exenatide
- NCT02838589Phase 2Completed
The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteers
Exenatide
- NCT03002675Phase 4Unknown
Exenatide and Brown Adipose Tissue
Exenatide
- NCT04008966Phase 4Completed
Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles
Gonadorelin
- NCT02787551Phase 3Completed
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
Liraglutide
- NCT02865681N/ACompleted
Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization
Gonadorelin